Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Asthma

Free Subscription Articles published in Respirology Retrieve available abstracts of 31 articles: HTML format

Single Articles

August 2025
1. MCDONALD CF
   Patients' and Health Professionals' Views on Using Oral Corticosteroids for Asthma: Priorities, Trade-Offs and Shared Decision-Making.
   Respirology. 2025 Aug 13. doi: 10.1111/resp.70102.
   PubMed    
   
   
   June 2025
2. HOWELL I, Noble J, Howell A, Morgan C, et al
   The Risk-Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New Zealand.
   Respirology. 2025 Jun 30. doi: 10.1111/resp.70077.
   PubMed     Abstract available
   
   
   
3. SHANTHIKUMAR S
   Paediatric Asthma Readmissions in Australia: Is Our Care Good Enough?
   Respirology. 2025 Jun 16. doi: 10.1111/resp.70080.
   PubMed    
   
   
   May 2025
4. THOMAS D, Lewthwaite H, Gibson PG, Majellano E, et al
   Unlocking Asthma Remission: Key Insights From an Expert Roundtable Discussion.
   Respirology. 2025 May 23. doi: 10.1111/resp.70047.
   PubMed     Abstract available
   
   
   
5. RASHID MM, Hu N, Khan JR, Chan M, et al
   The High Burden of Asthma Readmission Among Australian Children: A Population-Based Cohort Study.
   Respirology. 2025 May 13. doi: 10.1111/resp.70049.
   PubMed     Abstract available
   
   
   April 2025
6. OLVERA N, Agusti A, Vonk JM, Wang G, et al
   Heterogeneity of reduced FEV(1) in early adulthood: A looking forward, looking backwards analysis.
   Respirology. 2025;30:326-334.
   PubMed     Abstract available
   
   
   March 2025
7. FINGLETON J, McLachlan R, Sparks J, Beasley R, et al
   Treatable Trait Guided Asthma Management: A Feasibility Study.
   Respirology. 2025 Mar 12. doi: 10.1111/resp.70016.
   PubMed     Abstract available
   
   
   February 2025
8. BLAKEY JD, Ramakrishnan S
   Using an Eosinophil Count to Diagnose Asthma: Music to Your EARS?
   Respirology. 2025 Feb 25. doi: 10.1111/resp.70007.
   PubMed    
   
   
   
9. DONOVAN C
   Beyond Single Cytokines: Targeting Co-Receptor CD131 in Asthma-COPD Overlap.
   Respirology. 2025 Feb 2. doi: 10.1111/resp.14891.
   PubMed    
   
   
   
10. DI SIMONE SK, Forster SC
    Sputum Metagenomics Reveals Multidrug-Resistant Pseudomonas-Dominant Communities in Severe Asthma.
    Respirology. 2025 Feb 2. doi: 10.1111/resp.14890.
    PubMed    
    
    
    
11. WURZEL DF, Montgomery BD, Anderson N, Schneider-Futschik EK, et al
    Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement.
    Respirology. 2025;30:101-112.
    PubMed     Abstract available
    
    
    January 2025
12. MICHAUD A, Leigh R
    Assessing Disparities in Asthma and Respiratory Health in Indigenous People.
    Respirology. 2025 Jan 23. doi: 10.1111/resp.14885.
    PubMed    
    
    
    
13. WANG H, Fung NH, Aloe C, Miles M, et al
    CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma-COPD overlap mouse model originating in early life.
    Respirology. 2025 Jan 15. doi: 10.1111/resp.14877.
    PubMed     Abstract available
    
    
    December 2024
14. EATHORNE A, Noble J, Hatter L, Hills T, et al
    Reducing ethnic inequities: Patterns of asthma medication use and hospital discharges in Maori in Aotearoa New Zealand.
    Respirology. 2024 Dec 11. doi: 10.1111/resp.14865.
    PubMed     Abstract available
    
    
    
15. IVAN FX, Tiew PY, Jaggi TK, Thng KX, et al
    Sputum metagenomics reveals a multidrug resistant Pseudomonas-dominant severe asthma phenotype in an Asian population.
    Respirology. 2024 Dec 2. doi: 10.1111/resp.14863.
    PubMed     Abstract available
    
    
    October 2024
16. WEN X, Zhou J, Fang H, Li J, et al
    Allele-specific micro-RNA-mediated regulation of ADAM33 in childhood allergic asthma.
    Respirology. 2024 Oct 30. doi: 10.1111/resp.14846.
    PubMed     Abstract available
    
    
    
17. CHEN L, A Hoefel G, Pathinayake PS, Reid A, et al
    Inflammation-induced loss of CFTR-expressing airway ionocytes in non-eosinophilic asthma.
    Respirology. 2024 Oct 2. doi: 10.1111/resp.14833.
    PubMed     Abstract available
    
    
    
18. ZHANG X, Gray AR, Hancox RJ
    Predictors of lung function in early adulthood: A population-based cohort study.
    Respirology. 2024;29:897-904.
    PubMed     Abstract available
    
    
    July 2024
19. KANG N, Kim JH, Kim SR
    Letter from Korea-Oral corticosteroid stewardship in Korea: Insights from the Korean Severe Asthma Registry (KoSAR).
    Respirology. 2024 Jul 25. doi: 10.1111/resp.14806.
    PubMed    
    
    
    
20. MCDONALD CF, Bardin PG, MacDonald M
    Asthma-COPD overlap and asthma progressing to COPD: A complementary perspective.
    Respirology. 2024 Jul 14. doi: 10.1111/resp.14792.
    PubMed    
    
    
    
21. MELHORN J, Lavoie G
    Uncontrolled mild-to-moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping.
    Respirology. 2024 Jul 11. doi: 10.1111/resp.14795.
    PubMed    
    
    
    June 2024
22. POLITIS J, Bardin PG, Leong P
    Contemporary Concise Review 2023: Asthma.
    Respirology. 2024 Jun 28. doi: 10.1111/resp.14782.
    PubMed     Abstract available
    
    
    
23. KATELARIS CH
    Is remission the new target in asthma management?
    Respirology. 2024 Jun 27. doi: 10.1111/resp.14783.
    PubMed    
    
    
    
24. KONRADSEN JR, Selberg S, Odling M, Sundbaum JK, et al
    Treatable traits and exacerbation risk in patients with uncontrolled asthma prescribed GINA step 1-3 treatment: A nationwide asthma cohort study.
    Respirology. 2024 Jun 10. doi: 10.1111/resp.14774.
    PubMed     Abstract available
    
    
    
25. PELAIA C, Crimi C, Benfante A, Caiaffa MF, et al
    Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis.
    Respirology. 2024 Jun 7. doi: 10.1111/resp.14767.
    PubMed     Abstract available
    
    
    May 2024
26. QUINT JK
    Disentangling difficult-to-treat from severe asthma: What is the true prevalence?
    Respirology. 2024 May 27. doi: 10.1111/resp.14762.
    PubMed    
    
    
    
27. IRUSEN EM, Meiring D, Koegelenberg CFN
    Asthma-COPD overlap and asthma progressing to COPD: Are we using the right diagnostic approaches and pathways?
    Respirology. 2024 May 7. doi: 10.1111/resp.14731.
    PubMed    
    
    
    
28. DAVIS SR, Ampon RD, Poulos LM, Lee T, et al
    Prevalence and burden of difficult-to-treat and severe asthma in Australia: A national population survey.
    Respirology. 2024 May 6. doi: 10.1111/resp.14722.
    PubMed     Abstract available
    
    
    April 2024
29. KAN-O K
    Asthma-related death trends and biologics use for severe asthma in the super-aged society of Japan.
    Respirology. 2024 Apr 23. doi: 10.1111/resp.14729.
    PubMed    
    
    
    February 2024
30. JENKINS CR, Bardin P
    The long and winding road-Where to now for asthma?
    Respirology. 2024 Feb 29. doi: 10.1111/resp.14690.
    PubMed    
    
    
    
31. ROTHE T, Ubags N, von Garnier C
    What makes asthma characterized by airway eosinophilia become severe?
    Respirology. 2024 Feb 25. doi: 10.1111/resp.14685.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.